Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 7/20 | 0.60 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.55 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.55 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.54 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 5/20 | 0.53 |
| ▸ | RAB9A | P51151 | 3/20 | 0.53 |
| ▸ | KDR | P35968 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 6/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 3/20 | 0.52 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.52 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.51 |
| ▸ | MITF | O75030 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.51 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | SCD | O00767 | 1/20 | 0.50 |
| ▸ | MMP13 | P45452 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25822310 | 0.86 | KMT2A (0.82) | KMT2ANPC1RAB9AKDRMEN1 | |
| SCHEMBL16899268 | 0.86 | KMT2A (0.72) | KMT2ANPC1RAB9AKDRMEN1 | |
| SCHEMBL28808121 | 0.81 | RXFP1 (0.78) | KMT2ACHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL23286796 | 0.81 | KMT2A (0.77) | KMT2ACHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL29738098 | 0.81 | KMT2A (0.77) | KMT2ACHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL16899271 | 0.80 | KMT2A (0.60) | KMT2ANPC1RAB9AKDRMEN1 | |
| SCHEMBL28808130 | 0.80 | CHRNB2 (0.60) | KMT2ACHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL26310096 | 0.78 | MAPT (0.69) | KMT2ANPC1RAB9AKDRMEN1 | |
| SCHEMBL26673907 | 0.77 | KMT2A (0.60) | KMT2ANPC1RAB9AMEN1LMNA | |
| SCHEMBL8212003 | 0.77 | MEN1 (0.81) | KMT2ANPC1RAB9AKDRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230295114-A1 | AKT3 MODULATORS | Georgiamune Inc. | 2023-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230295114-A1 | AKT3 MODULATORS | AKT3, AKT2, MTOR | KMT2A 3925/4885CHRNB2 4618/4885CHRNA4 4732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.